DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20193197

Drug utilization pattern of psychotropic medicines in tertiary care centre of Bastar Region, Chhattisgarh, India

Ratna Agrawal, Marium K. A., Raj Kumar Sharma, Sanat Kumar Sharma, Mahendra Kumar Jaiswal

Abstract


Background: With the changing lifestyle, the incidence of psychiatric illness is increasing day by day. And the mental illnesses not only affect the social and personal life but also adds additional economic burden affecting quality of life of the person. So, proper diagnosis and management of psychiatric illnesses is utmost important. So, keeping this in mind, the present study has been conducted to evaluate drug utilization pattern of psychotropic medicines in tertiary care centre of Bastar region.

Methods: After obtaining approval from Institutional Ethics Committee, present study was conducted in 237 patients for a period of 3 months from February 2019 to April 2019. The data of patients attending psychiatry OPD was collected in a structured case record form. The data were analysed using graph pad prism version 6.0.

Results: Out of total 237 patients, males 136(57.38%) outnumbered females 101 (42.62%). The major psychiatric illness reported was schizophrenia (45.99%) followed by bipolar affective disorder (16%) and generalized anxiety disorder (14.35%). Average number of psychotropic drugs per prescription was 1.74±1.02. The percentage of drugs prescribed from state Essential drug List (EDL) was 93.05%.

Conclusions: Overall, the principles of rational prescribing was tried to be maintained, as polypharmacy has been avoided and most of the drugs were prescribed from the state EDL. The use of generic drugs should be increased to make prescriptions more rational and to cut down the cost of the therapy which may be helpful in increasing the quality of life of the patients.


Keywords


DDD, Drug utilization pattern, PDD, Prescribing pattern, Schizophrenia

Full Text:

PDF

References


Mental health in India. Available at: http://www.searo.who.int/india/topics/mental_health/about_mentalhealth/en/ [Accessed on 24/05/2019]

Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital. J Clin Diagn Res 2013 Dec;7(12):2759-2764.

[Doi: 10.7860/JCDR/2013/6760.3885]

Murthy R. Mental Health Programme in the 11th five year plan. The Indian Journal of Medical Research [Internet]. 2007 [cited 2012 Nov 21];11(June):707–12. Available from: http://www.ijmr.org.in/article.asp?issn=0971­5916 [Accessed on 24/05/2019]

Sharma P, Das S, Deshpande S. An estimate of the monthly cost of two major mental disorders in an Indian metropolis. Indian J Psychiatry. 2006;48:143–8.

WHO International Working Group for Drug Statistics Methodology. Introduction to drug utilization research [Internet]. Geneva: Who collaborating centre for drug utilization research and clinical pharmacology; 2003. Available from: https://apps.who.int/medicinedocs/en/d/Js4876e/ [Accessed on 24/05/2019].

Agrawal R, Rath B, Saha K, Mohapatra S. Drug utilization pattern of antidiabetic agents in a tertiary care hospital of western Odisha, India. Int J Basic Clin Pharmacol 2016;5: 2222-6. [Doi: http://dox.doi.org/10.18203/2319-2003.ijbcp.20163265]

WHO collaborating centre for drug statistics methodology. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2002. [Accessed on 24/05/2019]

ATC/DDD index 2019 [Internet]. WHO collaborating centre for Drug Statistics Methodology Norwegian Institute of Public Health. Available from: http://www.whocc.no/atc_ddd_index/. [Accessed on 28/05/2019]

Piparva KG, Parmar DM, Singh AP, Gajera MW, Trivedi HR. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med 2011;33(1): 54-58. [Doi: 10.4103/0253-7176.85396]

Sarkar P, Chakraborty K, Misra A, Shukla RK, Swain SP. Pattern of psychotropic prescription in a tertiary care centre: a critical analysis. Indian J Pharmacol 2013;45(3): 270-273. [Doi: 10.4103/0253-7613.111947]

Dutta SB, Dhasmana DC, Bhardwaj R. Psychotropic drug utilization pattern among patients with schizophrenia. Indian J Pschiatry 2005;47(4): 243-244. [Doi: 10.4103/0019-5545.43066]

Dhasmana DC, Rawat Y, Mishra KC. What is so atypical about atypical antipsychotic? Indian J Pharmacol 2003;35:322-4.

Kessing LV, Helmund G, Geddes JR, Goodwin GM, Anderson PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register- based cohort study. The Br J Psychiatry 2011;199(1):57-63.

[Doi: 10.1192/bjp.bp.110.084822]

Davis KL, Charney D, Coyle JT, Nemeroff C. Neuropsychopharmacology: The fifth generation of progress [Internet]. Philadelphia, Pennsylvania: Lippincott, William and Wilkins; 2002. Available from: http://www.acnp.org/g4/gn401000143/CH140.html.

NICE. Anxiety (CG22). National institute of health and clinical excellence. National collaborating centre for mental health; 2011. Available from: http://guidance.nice.org.uk/CG113. [Accessed on 30/05/2019]